Ingenio Device Algorithm Study

Inclusion Criteria: * Subjects who are willing and capable of providing informed consent to undergo a device implant and to participate in all testing associated with this clinical study; * Subjects whose age is 18 or above, or of legal age to give informed consent specific to national law; * Subjects indicated for a dual chamber pacemaker or a CRT-P device according to class I or class II indications of the standard ESC or ACC / AHA implant guidelines; * Subjects who are planned to be implanted with all leads intended for a specific device type (dual chamber pacemaker: atrial and right ventricular lead, CRT-P: atrial, right and left ventricular lead) or are already implanted with such leads; * Subjects who receive or are implanted with a bipolar atrial lead. Exclusion Criteria: * Women of childbearing potential who are or might be pregnant at the time of the study (method of assessment upon physician's discretion); * Enrolled in any other concurrent study, with the exception of local mandatory governmental registries and observational studies/registries that are not in conflict or affect * Schedule of procedures for IVORY (i.e. should not cause additional or missed visits); * Programming of devices for IVORY per CIP; * IVORY outcome (i.e. involve medications that could affect the heart rate of the subject); * Conduct of IVORY per GCP / ISO 14 155:2011 / local regulations. * Subjects who live at such a distance from the clinic that travels for FU visits at a study center w…